Ethylenediamine derivatives
US7192968B2 · kind B2 · utility
17Cited by
9References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 5, 2001 |
| Grant date | Mar 20, 2007 |
| Priority date | — |
| Expiry date | Apr 5, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D498/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates a compound represented by the formula (1):Q1-Q2-C(═O)—N(R1)-Q3-N(R2)-T1-Q4 (1)wherein R1 and R2 represent H or the like; Q1 represents an aromatic ring, heterocyclic ring or the like; Q2 represents a single bond, aromatic ring, heterocyclic ring or the like; Q3 represents a group or the like, Q4 represents an aromatic ring, heterocyclic ring or the like; and T1 represents —CO— or —SO2—, and a medicine which comprises the compound and is useful for thrombosis and embolism.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.